SCNI vs SRE · P/E 0.2, rev $1.3M vs P/E 31, rev $13.70B
Scinai Immunotherapeutics Ltd (SCNI) versus Sempra Energy (SRE) — a side-by-side from cached financials, not a winner call.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
Sempra Energy (SRE) is a utilities - diversified company listed on US.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
Latest reported SRE revenue for 2025-12-31 was $13.70B. Net income was $1.84B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
SCNI currently screens at market cap $1.8M and trailing P/E 0.2. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
Not investment advice. Open the SCNI and SRE stock pages for the full models.
Not investment advice.